| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.00089 | 1 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.00085 | 1 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.00085 | 1 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.00087 | 1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.001 | 1 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.0007 | 1 |